SCHEMBL16294248

SCHEMBL16294248

OCCc1cc(Br)ccc1OCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
USP28 Q96RU2 1/20 0.69
USP25 Q9UHP3 1/20 0.69
HTT P42858 2/20 0.67
ALDH1A1 P00352 3/20 0.63
CCR5 P51681 4/20 0.61
LMNA P02545 2/20 0.60
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.54
PTGER1 P34995 6/20 0.53
STAT3 P40763 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8406943 0.88 HTR1A (0.65) USP28USP25HTTALDH1A1CCR5
SCHEMBL4680227 0.88 USP28 (0.68) USP28USP25HTTALDH1A1CCR5
SCHEMBL17197395 0.88 CCR5 (0.62) USP28USP25HTTALDH1A1CCR5
SCHEMBL27402118 0.86 CCR5 (0.60) USP28USP25HTTALDH1A1CCR5
SCHEMBL5210786 0.85 CCR5 (0.63) USP28USP25HTTALDH1A1CCR5
SCHEMBL6260325 0.85 CCR5 (0.59) USP28USP25HTTALDH1A1CCR5
SCHEMBL16293879 0.85 CCR5 (0.59) USP28USP25HTTALDH1A1CCR5
SCHEMBL16294058 0.84 PTGER1 (0.64) USP28USP25HTTALDH1A1CCR5
SCHEMBL7585417 0.84 CCR5 (0.58) USP28USP25HTTALDH1A1CCR5
SCHEMBL15196646 0.83 CCR5 (0.63) USP28USP25HTTALDH1A1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008052-A1 MACROCYCLIC FACTOR VIIA INHIBITORS Bristol-Myers Squibb Company (US) 2016-04-20 EP disclosed
WO-2014201073-A9 MACROCYCLIC FACTOR VIIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-10-08 WO disclosed
WO-2014201073-A1 MACROCYCLIC FACTOR VIIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-12-18 WO disclosed